Advertisement

Clinical Rheumatology

, Volume 38, Issue 2, pp 279–283 | Cite as

The incidence of idiopathic inflammatory myopathies in the adult Slovenian population

  • Jaka OstrovršnikEmail author
  • Alojzija Hočevar
  • Žiga Rotar
  • Monika Krošel
  • Saša Čučnik
  • Vesna Jurčić
  • Matija Tomšič
Original Article
Part of the following topical collections:
  1. Rheumatology in Slovenia: Clinical practice and translational research

Abstract

Idiopathic Inflammatory myopathies (IIM) are rare disorders. The aim of our study was to determine the incidence of IIM in a well-defined Slovenian region. This retrospective study was conducted at the Department of Rheumatology, University Medical Centre Ljubljana, the only secondary/tertiary rheumatology center in a region with a population of 704,342 adults. We identified potential IIM cases by searching the electronic patient records for ICD-10 codes M33, M35.1, M35.8, M60, G72, G73, and J84. We included incipient IIM cases between January 2010 and December 2017, who were at the time of the diagnosis, residents of the inspected region. To avoid under-reporting due to miscoded cases, we obtained a list of the patients who had histological patterns consistent with IIM on muscle biopsy from the Institute of Pathology. The annual incidence rate for IIM was calculated. During the eight-year observation period, we identified 65 IIM cases (72.3% female, median (IQR) patient age 64.8 (54.8–73.2) years). The estimated annual incidence of IIM in the studied population was 11.5 (95% CI 9.0–14.6) per 106 adults, in females 16.2 (95% CI 12.1–21.4), and in males 6.6 (95% CI 4.0–10.2) per 106 adults. The incidence rate of IIM in Slovenia is consistent with data from the literature.

Keywords

Epidemiology Incidence Inflammatory myopathy 

Notes

Funding statement

The study was supported by the Slovenian Research Agency (ARRS) for the National Research Programme P3–0314.

Compliance with ethical standards

Disclosures

None.

Ethics committee approval

The study was approved by the National Medical Ethics Committee.

References

  1. 1.
    Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734–1747.  https://doi.org/10.1056/NEJMra1402225 CrossRefGoogle Scholar
  2. 2.
    Dobloug GC, Svensson J, Lundberg IE, Holmqvist M (2018) Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis 77:40–47.  https://doi.org/10.1136/annrheumdis-2017-211402 CrossRefGoogle Scholar
  3. 3.
    Ramanan AV, Feldman BM (2002) Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin N Am 28:833–857CrossRefGoogle Scholar
  4. 4.
    Pearson CM (1966) Polymyositis. Annu Rev Med 17:63–82.  https://doi.org/10.1146/annurev.me.17.020166.000431 CrossRefGoogle Scholar
  5. 5.
    Smoyer-Tomic KE, Amato AA, Fernandes AW (2012) Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis. BMC Musculoskelet Disord 13:103.  https://doi.org/10.1186/1471-2474-13-103 CrossRefGoogle Scholar
  6. 6.
    Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology 54:50–63.  https://doi.org/10.1093/rheumatology/keu289 CrossRefGoogle Scholar
  7. 7.
    Ahlström G, Gunnarsson L-G, Leissner P, Sjödén P-O (1993) Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. Neuroepidemiology 12:262–269.  https://doi.org/10.1159/000110327 CrossRefGoogle Scholar
  8. 8.
    Weitoft T (1997) Occurrence of polymyositis in the county of Gävleborg, Sweden. Scand J Rheumatol 26:104–106CrossRefGoogle Scholar
  9. 9.
    Mendez EP, Lipton R, Ramsey-Goldman R, Roettcher P, Bowyer S, Dyer A, Pachman LM, For the NIAMS Juvenile DM Registry Physician Referral Group (2003) US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300–305.  https://doi.org/10.1002/art.11122 CrossRefGoogle Scholar
  10. 10.
    Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet (London, England) 360:1197–1202.  https://doi.org/10.1016/S0140-6736(02)11279-7 CrossRefGoogle Scholar
  11. 11.
    Bohan A, Peter JB, Bowman RL, Pearson CM (1977) Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56:255–286CrossRefGoogle Scholar
  12. 12.
    Tymms KE, Webb J (1985) Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol 12:1140–1148Google Scholar
  13. 13.
    Hengstman GJ, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen B (2000) The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient. Ann Rheum Dis 59:141–142.  https://doi.org/10.1136/ARD.59.2.141 CrossRefGoogle Scholar
  14. 14.
    Love LA, Weinberg CR, McConnaughey DR et al (2009) Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum 60:2499–2504.  https://doi.org/10.1002/art.24702 CrossRefGoogle Scholar
  15. 15.
    Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW, for the International Myositis Collaborative Study Group (2003) Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 48:2285–2293.  https://doi.org/10.1002/art.11090 CrossRefGoogle Scholar
  16. 16.
    Sontheimer RD (1996) Photoimmunology of lupus erythematosus and dermatomyositis: a speculative review. Photochem Photobiol 63:583–594CrossRefGoogle Scholar
  17. 17.
    Patrick M, Buchbinder R, Jolley D, Dennett X, Buchanan R (1999) Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol 26:1094–1100Google Scholar
  18. 18.
    Medsger TA, Dawson WN, Masi AT (1970) The epidemiology of polymyositis. Am J Med 48:715–723CrossRefGoogle Scholar
  19. 19.
    Svensson J, Holmqvist M, Lundberg IE, Arkema EV (2017) Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study. Ann Rheum Dis 76:1803–1808.  https://doi.org/10.1136/annrheumdis-2017-211174 CrossRefGoogle Scholar
  20. 20.
    Kendall FP (2005) Muscles: testing and function with posture and pain, 5th ed. Lippincott Williams & Wilkins, BaltimoreGoogle Scholar
  21. 21.
    Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, Vencovsky J, de Visser M, Hughes RA (2004) 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 14:337–345.  https://doi.org/10.1016/j.nmd.2004.02.006 CrossRefGoogle Scholar
  22. 22.
    Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dankó K, Dimachkie MM, Feldman BM, Torre IG, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O’Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, International Myositis Classification Criteria Project consortium, The Euromyositis register and The Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) (2017) 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955–1964.  https://doi.org/10.1136/annrheumdis-2017-211468 CrossRefGoogle Scholar
  23. 23.
    Hočevar A, Rotar Z, Krosel M et al (2017) Performance of the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies in clinical practice. Ann Rheum Dis.  https://doi.org/10.1136/annrheumdis-2017-212774
  24. 24.
    Tan JA, Roberts-Thomson PJ, Blumbergs P et al (2013) Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases. Int J Rheum Dis 16(3):331–338.  https://doi.org/10.1111/j.1756-185X.2011.01669.x CrossRefGoogle Scholar
  25. 25.
    Danielsson O, Lindvall B, Gati I, Ernerudh J (2013) Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients. J Rheumatol 40:1173–1182.  https://doi.org/10.3899/jrheum.120804 CrossRefGoogle Scholar
  26. 26.
    Manta P, Kalfakis N, Vassilopoulos D (1989) Evidence for seasonal variation in polymyositis. Neuroepidemiology 8:262–265.  https://doi.org/10.1159/000110192 CrossRefGoogle Scholar
  27. 27.
    Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin N Am 28:723–741CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2018

Authors and Affiliations

  • Jaka Ostrovršnik
    • 1
    Email author
  • Alojzija Hočevar
    • 1
    • 2
  • Žiga Rotar
    • 1
  • Monika Krošel
    • 1
  • Saša Čučnik
    • 1
    • 3
  • Vesna Jurčić
    • 2
    • 4
  • Matija Tomšič
    • 1
    • 4
  1. 1.Department of RheumatologyUniversity Medical Centre LjubljanaLjubljanaSlovenia
  2. 2.Faculty of MedicineUniversity of LjubljanaLjubljanaSlovenia
  3. 3.Faculty of PharmacyUniversity of LjubljanaLjubljanaSlovenia
  4. 4.Institute of Pathology, Faculty of MedicineUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations